Wealth Enhancement Advisory Services
SGMO

Wealth Enhancement Advisory Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,000
Closed -$21.6K – 4215
2026
Q1 		$21.6K Buy
72,000
+26,700
+59% +$10.6K ﹤0.01% 3494
2025
Q4 		$20.1K Buy
45,300
+35,000
+340% +$18.6K ﹤0.01% 3587
2025
Q3 		$7.19K Sell
10,300
-80,250
-89% -$43.3K ﹤0.01% 3569
2025
Q2 		$47.7K Buy
90,550
+21,300
+31% +$12.6K ﹤0.01% 3231
2025
Q1 		$45.4K Sell
69,250
-53,213
-43% -$56.3K ﹤0.01% 2857
2024
Q4 		$125K Buy
122,463
+13,518
+12% +$24.7K ﹤0.01% 2776
2024
Q3 		$94.4K Buy
108,945
+38,850
+55% +$28.5K ﹤0.01% 2567
2024
Q2 		$25.1K Buy
70,095
+21,000
+43% +$11.3K ﹤0.01% 2479
2024
Q1 		$32.9K Buy
49,095
+14,095
+40% +$10.2K ﹤0.01% 2364
2023
Q4 		$19K Buy
+35,000
New +$16.1K ﹤0.01% 2258

Other funds holding SGMO

AIM
Axiom Investment Management New York $150M AUM
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Wealth Enhancement Advisory Services's SGMO Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 72,000 shares — an estimated $21.6K sold.

Wealth Enhancement Advisory Services first reported a position in SGMO in Q4 2023 and held it in 10 quarters. The position peaked at $125K in Q4 2024. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 72,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $21.6K.
  • Wealth Enhancement Advisory Services first reported a position in SANGAMO THERAPEUTICS INC in Q4 2023 and held it in 10 quarters.
  • Wealth Enhancement Advisory Services's SANGAMO THERAPEUTICS INC position peaked at $125K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.